IL2 and type 1 diabetes mellitus: In particular, individuals with IL2RA susceptibility genotypes is associated with lower expression of IL-2Rα on Tregs and lower IL-2 production by Teff cells, both of which may impair Foxp3 expression and Treg function.[34] Clinical trial of IL-2 administration in T1D subjects has thus been attempted.